Cargando…
Tumor Biomarker Testing for Metastatic Colorectal Cancer: a Canadian Consensus Practice Guideline
The systemic therapy management of metastatic colorectal cancer (mCRC) has evolved from primarily cytotoxic chemotherapies to now include targeted agents given alone or in combination with chemotherapy, and immune checkpoint inhibitors. A better understanding of the pathogenesis and molecular driver...
Autores principales: | Yu, Irene S., Aubin, Francine, Goodwin, Rachel, Loree, Jonathan M., Mather, Cheryl, Sheffield, Brandon S., Snow, Stephanie, Gill, Sharlene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310231/ https://www.ncbi.nlm.nih.gov/pubmed/35898967 http://dx.doi.org/10.1177/17588359221111705 |
Ejemplares similares
-
Canadian Colorectal Cancer Screening Guidelines: Do They Need an Update Given Changing Incidence and Global Practice Patterns?
por: Kalyta, Anastasia, et al.
Publicado: (2021) -
2003 Canadian Asthma Consensus Guidelines Executive Summary
por: Becker, Allan, et al.
Publicado: (2006) -
Abstracts of the 2021 Canadian Association of Medical Oncologists Annual Meeting
por: Loree, Jonathan, et al.
Publicado: (2021) -
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019
por: Gotfrit, Joanna, et al.
Publicado: (2021) -
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC
por: Cheema, Parneet K., et al.
Publicado: (2023)